Global Prothioconazole (CAS 178928-70-6) Market 2016-2021 : Bayer, Jiangsu Furun

This report provides detailed analysis of worldwide markets for Prothioconazole (CAS 178928-70-6) from 2011-2016, and provides extensive market forecasts (2016-2021) by region/country and subsectors. It covers the key technological and market trends in the Prothioconazole (CAS 178928-70-6) market and further lays out an analysis of the factors influencing the supply/demand for Prothioconazole (CAS 178928-70-6), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

Request for sample report at http://www.fiormarkets.com/report-detail/716/request-sample

Prothioconazole is a synthetic compound of the triazolinthione family of compounds. It is a broad spectrum systemic fungicide, with curative, preventative and eradicative action. It can be used as both a seed treatment and a foliar treatment. Its mode of action is interference with the synthesis of ergosterol in the target fungi by inhibition of CYP51, which catalyses demethylation at C14 of lanosterol or 24-methylene dihydrolanosterol, leading to morphological and functional changes in the fungal cell membrane. After absorption it moves into cells of the target organisms, effecting sterol biosynthesis and thereby disrupting membrane structure. This ultimately effects hyphal growth and germ tube elongation. Fungi susceptible to prothioconazole include early leaf spot (Mycosphaerella arachidis), eyespot, Fusarium spp., powdery mildew, net blotch, phoma leaf spot, Rhynchosporium secalis, Sclerotinia sclerotiorum, Sclerotium rolfsii, Septoria tritici, Septoria nodorum, rust and tan spot. Prothioconazole is approved for use on barley, durum wheat, oats, oilseed rape (winter), rye (winter), dried shell pea and bean (except soybean), peanut, rice and wheat. Prothioconazole is sold in combination with numerous other fungicides, including bifaxen, spiroxamine, tebuconazole, fluoxastrobin, trifloxystrobin and floupyram.

Access full report at http://www.fiormarkets.com/report/global-prothioconazole-cas-178928-70-6-industry-report-2016-716.html

Global Prothioconazole (CAS 178928-70-6) Industry Report 2016, has been prepared based on the synthesis, analysis, and interpretation of information about the global Prothioconazole (CAS 178928-70-6) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Prothioconazole (CAS 178928-70-6) market areBayer, Jiangsu Furun.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Prothioconazole (CAS 178928-70-6) industry has been provided.

Fior Markets is a leading market intelligence company that sells reports of top publishers in the technology industry.

Our extensive research reports cover detailed market assessments that include major technological improvements in the industry. Fior Markets also specializes in analyzing hi-tech systems and current processing systems in its expertise.

We have a team of experts that compile precise research reports and actively advise top companies to improve their existing processes. Our experts have extensive experience in the topics that they cover.

Fior Markets provides you the full spectrum of services related to market research, and corroborate with the clients to increase the revenue stream, and address process gaps.

Contact Us

Mark Stone
Sales Manager
2566, Lincoln Street
Princeton,
New Jersey 08540
USA
Phone: (201) 465-4211
Email: sales@fiormarkets.com
Web: www.fiormarkets.com
Blog: www.9dimenreports.com

This release was published on openPR.